Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moskowitz

Showing results (11-20 of 298) with videos related to

Pageof 30
Sort By:
Journal of Oncology Practice|March 13, 2019
Practical Treatment Approach for Angioimmunoblastic T-Cell LymphomaAlison J Moskowitz
Haematologica|April 2, 2026
Relapsed Hodgkin disease: Should all patients receive an autologous stem cell transplant? - the CONAlison J Moskowitz
Leukemia & Lymphoma|October 16, 2014
New frontiers for brentuximab vedotin for lymphomasAlison J Moskowitz
Blood|May 7, 2016
Bleomycin for older patients: less is moreAlison J Moskowitz
The Lancet. Haematology|March 8, 2016
Lenalidomide in adult T-cell leukaemia-lymphomaAlison J Moskowitz
Hematology. American Society of Hematology. Education Program|December 9, 2022
Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?Alison J Moskowitz
Hematology. American Society of Hematology. Education Program|December 4, 2018
Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapyAlison J Moskowitz
Current Oncology Reports|June 19, 2012
Novel agents in Hodgkin lymphomaAlison J Moskowitz
Circulation|November 1, 1983
The National Heart, Lung and Blood Institute: a plan for the eightiesC Lenfant, J Moskowitz
The American Review of Respiratory Disease|February 1, 1976
Editorial: Pulmonary research training--a changing sceneC Lenfant, J Moskowitz
Pageof 30

Showing results (11-20 of 298) with videos related to

Sort By:
Pageof 30
Journal of Oncology Practice|March 13, 2019
Practical Treatment Approach for Angioimmunoblastic T-Cell LymphomaAlison J Moskowitz
Haematologica|April 2, 2026
Relapsed Hodgkin disease: Should all patients receive an autologous stem cell transplant? - the CONAlison J Moskowitz
Leukemia & Lymphoma|October 16, 2014
New frontiers for brentuximab vedotin for lymphomasAlison J Moskowitz
Blood|May 7, 2016
Bleomycin for older patients: less is moreAlison J Moskowitz
The Lancet. Haematology|March 8, 2016
Lenalidomide in adult T-cell leukaemia-lymphomaAlison J Moskowitz
Hematology. American Society of Hematology. Education Program|December 9, 2022
Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?Alison J Moskowitz
Hematology. American Society of Hematology. Education Program|December 4, 2018
Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapyAlison J Moskowitz
Current Oncology Reports|June 19, 2012
Novel agents in Hodgkin lymphomaAlison J Moskowitz
Circulation|November 1, 1983
The National Heart, Lung and Blood Institute: a plan for the eightiesC Lenfant, J Moskowitz
The American Review of Respiratory Disease|February 1, 1976
Editorial: Pulmonary research training--a changing sceneC Lenfant, J Moskowitz
Pageof 30